BOSTON MEDICAL CENTER CORPORATION
DBA: BMC
BOSTON, MASSACHUSETTS 021182308
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 622110 | $1.82M | 11 |
| 621399 | $417K | 3 |
| 611310 | $320K | 3 |
| 541714 | $251K | 13 |
| 622310 | $184K | 9 |
| 541715 | $67K | 5 |
| 325413 | $-93,887.36 | 3 |
Contract Awards
29 awards found
EDUCATION COST SHARING
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
NICHD: R&D: TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES: SEVERABLE
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
ONSITE OPHTHALMOLOGY SERVICES
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
ONSITE OPHTHALMOLOGY SERVICES
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
EDUCATION COSTS
CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING
TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS AND THE PHARMACODYNAMIC EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
CORE FUNCTION ACTIVITIES-TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT, AND FUTURE OF THE CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE SITES) ACTIVITIES.
LARC STUDY
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183
TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS AND THE PHARMACODYNAMIC EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
BOSTON MEDICAL CENTER:1106016 [18-066657]
CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC) IMAGING
EDUCATION COSTS
CORE FUNCTION ACTIVITIES-TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT, AND FUTURE OF THE CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE SITES) ACTIVITIES.
CORE FUNCTION ACTIVITIES TASK ORDER FOR ADVISORY SERVICES AND ADMINISTRATIVE REPORTING
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
BOSTON MEDICAL - CISA CLINICAL CONTRIBUTING
Business Details
- UEI
- JZ8RQC4EMDZ5
- CAGE Code
- 09PZ2
- Address
- 88 EAST NEWTON ST
BOSTON, MA 021182308 - Congressional District
- MA-07
- Phone
- 6176387388
Parent Company
BOSTON MEDICAL CENTER CORPORATION
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov